Marcus Maurer

Marcus Maurer

Department Of Dermatology, Charité ‐ Universitätsmedizin Berlin, Corporate Member Of Freie Universität Berlin, Humboldt‐universität Zu Berlin, And Berlin Institute Of Health, ...

Direct Impact

Concepts for which Marcus Maurer has direct influence:

chronic spontaneous urticaria
mast cells
hereditary angioedema
allergic rhinitis
atopic dermatitis
schnitzler syndrome
cold agglutinins

External impact

Concepts related to the work of other authors for which Marcus Maurer has influence:

chronic urticaria
hereditary angioedema
mast cells
allergic rhinitis
atopic dermatitis
inhibitor deficiency
severe covid-19

Prominent publications by Marcus Maurer

KOL-Index: 449 Hereditary angioedema (HAE) is a rare and disabling disease for which early diagnosis and effective therapy are critical. This revision and update of the global WAO/EAACI guideline on the diagnosis and management of HAE provides up-to-date guidance for the management of HAE. For this update and revision of the guideline, an international panel of experts reviewed the existing evidence, ...
Known for
Prophylactic | Experts | Standards | Revision Guideline
KOL-Index: 252 Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR ...
Known for
Plan European | Alliance | Collaboration | Individualised Predictive
KOL-Index: 140 Patients with chronic spontaneous urticaria (CSU) are widely held to often have other autoimmune disorders, including autoimmune thyroid disease. Here, we systematically evaluated the literature on the prevalence of thyroid autoimmunity in CSU and vice versa. There is a strong link between CSU and elevated levels of IgG antithyroid autoantibodies (AAbs), with most of a large number of ...
Known for
Aabs Csu | Antithyroid | Weak Elevated
KOL-Index: 139 Hereditary Angioedema (HAE) is a rare and disabling disease. Early diagnosis and appropriate therapy are essential. This update and revision of the global guideline for HAE provides up-to-date consensus recommendations for the management of HAE. In the development of this update and revision of the guideline, an international expert panel reviewed the existing evidence and developed 20 ...
Known for
20 Recommendations | Dysfunctional C1-Inhibitor | Management Incorporate Self-Administration | Reviewers
KOL-Index: 136 Chronic spontaneous urticaria (CSU) imposes a significant burden on patients, families and healthcare systems. Management is difficult, due to disease heterogeneity and insufficient efficacy of classical drugs such as H1 R-antihistamines. Better understanding of the mechanisms has enabled a stratified approach to the management of CSU, supporting the use of targeted treatment with ...
Known for
Future Therapeutic Approaches | Clarification | Priorities | Omalizumab Csu
KOL-Index: 111 Guidelines for the treatment of chronic spontaneous urticaria (CSU) recommend the use of the IgE-targeted biologic omalizumab in patients with antihistamine-refractory disease. The rationale for this is supported by the key role of IgE and its high-affinity receptor, FcεRI, in the degranulation of skin mast cells that drives the development of the signs and symptoms of CSU, itchy wheals, and ...
Known for
Sialic Acid-Binding Ig-Like Lectin | Angioedema | Antihistamine-Refractory | Ige-Targeted Biologic Omalizumab
KOL-Index: 111 The study of autoimmunity mediated by immunoglobulin E (IgE) autoantibodies, which may be termed autoallergy, is in its infancy. It is now recognized that systemic lupus erythematosus, bullous pemphigoid (BP), and chronic urticaria, both spontaneous and inducible, are most likely to be mediated, at least in part, by IgE autoantibodies. The situation in other conditions, such as autoimmune ...
Known for
Cellular Molecular Effects | Ige-Targeted Therapies | Chronic Spontaneous Urticaria | Mediated Autoallergy
KOL-Index: 109 Chronic urticaria (CU) affects about 1% of the world population of all ages, mostly young and middle-aged women. It usually lasts for several years (> 1 year in 25-75% of patients) and often takes > 1 year before effective management is implemented. It presents as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) or both in the same person. More than 25% of cases are ...
Known for
Costs Annual | Oedema | Ppp | Csu Angio
KOL-Index: 106 BACKGROUND AND OBJECTIVES: Urticaria is a frequent skin condition, but reliable prevalence estimates from population studies particularly of the chronic form are scarce. The objective of this study was to systematically evaluate and summarize the prevalence of chronic urticaria by evaluating population-based studies worldwide. METHODS: We performed a systematic search in PUBMED and EMBASE ...
Known for
Urticaria Time | Children Sex | Meta 000
KOL-Index: 106 Chronic spontaneous urticaria (CSU) is defined as persistent wheals, angioedema, or both lasting for >6 weeks due to known or unknown causes. Some epidemiological studies and case reports suggest that internal parasite infections (PI) can cause CSU. Here, we provide a systematic overview of published findings on the prevalence and relevance of PI in CSU and we discuss possible ...
Known for
Csu Ranged | 0 100 | Blastocystis Hominis Allele | Pathomechanisms

Department of Dermatology, Charité ‐ Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt‐Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

https://www.g2.com/products/key-opinion-leaders-kols/reviews https://www.bbb.org/us/fl/doral/profile/data-analytics/key-opinion-leaders-0633-92023858 https://www.trustpilot.com/review/keyopinionleaders.com https://www.yelp.com/biz/key-opinion-leaders-miami


© 2022 - Key Opinion Leaders -
Key Opinion Leaders, LLC ,
2025 NW 102 Avenue, Suite 111 Doral , FL   33172